U.S. markets closed
  • S&P Futures

    3,831.50
    -2.50 (-0.07%)
     
  • Dow Futures

    30,908.00
    -28.00 (-0.09%)
     
  • Nasdaq Futures

    11,811.00
    +2.50 (+0.02%)
     
  • Russell 2000 Futures

    1,738.00
    -3.70 (-0.21%)
     
  • Crude Oil

    99.96
    +0.46 (+0.46%)
     
  • Gold

    1,768.90
    +5.00 (+0.28%)
     
  • Silver

    19.04
    -0.01 (-0.06%)
     
  • EUR/USD

    1.0269
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    2.8090
    -0.0800 (-2.77%)
     
  • Vix

    27.54
    +0.01 (+0.04%)
     
  • GBP/USD

    1.1962
    +0.0011 (+0.09%)
     
  • USD/JPY

    135.3590
    -0.4830 (-0.36%)
     
  • BTC-USD

    19,920.38
    -360.01 (-1.78%)
     
  • CMC Crypto 200

    431.07
    -8.96 (-2.04%)
     
  • FTSE 100

    7,025.47
    -207.18 (-2.86%)
     
  • Nikkei 225

    26,112.28
    -311.19 (-1.18%)
     

Ocugen shares jump premarket after FDA lifts clinical hold on trial of COVID-19 vaccine candidate

·1 min read
Ocugen shares jump premarket after FDA lifts clinical hold on trial of COVID-19 vaccine candidate
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Ocugen Inc. shares jumped 9% premarket Monday, after the biotech said the Food and Drug Administration has lifted its clinical hold on Ocugen's Phase 2/3 trial of its COVID-19 vaccine candidate Covaxin. "We're extremely pleased that we can proceed with our clinical trials for COVAXIN(TM), our whole virus inactivated COVID-19 vaccine candidate. The need for delivering an additional, differentiated vaccine option, we believe, remains a priority," said Dr. Shankar Musunuri, CEO and co-founder of Oc